Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Healios K.K. | 6VX | May 17, 2024 | 0.83 | -0.60 |
Hemogenyx Pharmaceuticals Plc | 5HU | May 17, 2024 | 0.01 | 0.00 |
HUTCHMED (China) Limited | H7T2 | May 17, 2024 | 3.64 | -4.21 |
Hybrigenics | 3HB | May 17, 2024 | 0.00 | +4.35 |
Hyloris Pharmaceuticals SA | 52U | May 17, 2024 | 11.40 | 0.00 |
Immupharma Plc | 25I | May 17, 2024 | 0.02 | 0.00 |
Immutep Limited | YP1B | May 17, 2024 | 0.26 | +2.38 |
Inhibrx, Inc. | 1RK | May 17, 2024 | 31.40 | 0.00 |
Innovent Biologics Inc | 6IB | May 17, 2024 | 4.68 | +0.86 |
Inventiva S.A. - American Depository Shares | 6IVA | May 17, 2024 | 3.54 | +4.12 |
Ixico Plc | PYPB | May 17, 2024 | 0.08 | 0.00 |
Legend Biotech Corporation - American Depositary Shares | 9LB | May 17, 2024 | 41.20 | -2.37 |
Mabion S.A. | 272 | May 17, 2024 | 4.08 | +0.74 |
Medesis Pharma S.A. | 76D | May 17, 2024 | 0.91 | -17.27 |
Medmira Inc | 47M | May 17, 2024 | 0.05 | -5.45 |
Memphasys Limited | IG7 | May 17, 2024 | 0.00 | 0.00 |
Mesoblast Ltd | LWB | May 17, 2024 | 0.64 | +0.79 |
Nanocarrier Co Ltd | 3NQ | May 17, 2024 | 0.79 | +5.37 |
NetScientific plc | NTK1 | May 17, 2024 | 0.68 | 0.00 |
Newron Pharmaceuticals Spa. | NP5 | May 17, 2024 | 10.60 | +1.15 |
Nuformix plc | 1RT | May 17, 2024 | 0.00 | 0.00 |
Ocumension Therapeutics | 5DG | May 17, 2024 | 0.80 | 0.00 |
Oncimmune Holdings plc | OCY | May 17, 2024 | 0.22 | 0.00 |
Oncoarendi Therapeutics SA | 1B1 | May 17, 2024 | 3.36 | -0.15 |
Oncotherpapy Science Inc | 30O | May 17, 2024 | 0.07 | -6.94 |
Open Orphan plc | CRO | May 17, 2024 | 0.30 | -0.66 |
Opthea Limited | UKJ | May 17, 2024 | 0.40 | 0.00 |
OptiBiotix Health plc | OB3 | May 17, 2024 | 0.21 | +3.00 |
Oric Pharmaceuticals, Inc. | 4TZ | May 17, 2024 | 8.15 | -2.40 |
Oxford BioDynamics plc | LMQ | May 17, 2024 | 0.05 | -5.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.